Torrent Pharma

Torrent Pharma, established in 1971, is the flagship enterprise of the Torrent Group and a prominent pharmaceutical company in India, boasting a significant and expanding international footprint. The company is recognized for its leadership in key therapeutic areas, including cardiovascular health, central nervous system disorders, gastro-intestinal care, vitamins, minerals, and nutritionals, alongside cosmo-dermatology. It also maintains a substantial presence in diabetology, pain management, gynaecology, oncology, and anti-infective treatments, demonstrating a comprehensive approach to healthcare solutions.

Driven by a commitment to scientific excellence and innovation, Torrent Pharma prioritizes research and development, supported by advanced infrastructure and a highly skilled scientific workforce. This dedication ensures the development of high-quality, affordable medicines for a global patient base. The company operates with a substantial scale, employing over 10,000 employees across its operations and maintaining a presence in 10 distinct locations. Its operational capabilities are further highlighted by numerous hashtags indicating extensive global reach and specialized departments.

Torrent Pharma's strategic focus on innovation and quality has solidified its position in the global pharmaceutical market. With a revenue of $1.3B, the company continues to expand its therapeutic offerings and geographic penetration, serving markets across North America, Europe, Asia, and Africa. Understanding the human capital behind this success is crucial; Meet Torrent Pharma's team to gain insight into the leadership and expertise driving its mission. The company's extensive operational network and diverse product portfolio underscore its role as a key player in the healthcare industry.